🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
4,720 results for “eu”
MedicineActive substanceLicence holderStatus
Kalydeco 50 mg granules in sachet
EU/1/12/782/003
Ivacaftor Vertex Pharmaceuticals (Ireland) Limited
Kalydeco 59.5 mg granules in sachet
EU/1/12/782/008
Ivacaftor Vertex Pharmaceuticals (Ireland) Limited
Kalydeco 75 mg film-coated tablets
EU/1/12/782/007
Ivacaftor Vertex Pharmaceuticals (Ireland) Limited
Kalydeco 75 mg granules in sachet
EU/1/12/782/004
Ivacaftor Vertex Pharmaceuticals (Ireland) Limited
KANJINTI 150 mg powder for concentrate for solution for infusion
EU/1/18/1281/001
Trastuzumab Amgen Europe B.V.
KANJINTI 420 mg powder for concentrate for solution for infusion
EU/1/18/1281/002
Trastuzumab Amgen Europe B.V.
KANUMA 2 mg/ml concentrate for solution for infusion
EU/1/15/1033/001
Sebelipase alfa Alexion Europe SAS
Kapake 15mg/500mg Tablets
PA1418/020/001
Paracetamol, Codeine phosphate hemihydrate Athlone Pharmaceuticals Limited Not marketed
Kapake 30 mg/500 mg Tablets
PA1418/020/002
Paracetamol, Codeine phosphate hemihydrate Athlone Pharmaceuticals Limited Not marketed
Kapruvia 50 micrograms/mL solution for injection
EU/1/22/1643/001-002
Difelikefalin Acetate Vifor France
Karvea 150 mg film-coated tablets
EU/1/97/049/021-025
Irbesartan Sanofi Winthrop Industrie
Karvea 150 mg tablets
EU/1/97/049/004-006
Irbesartan Sanofi Winthrop Industrie
Karvea 300 mg film-coated tablets
EU/1/97/049/026-030
Irbesartan Sanofi Winthrop Industrie
Karvea 300 mg tablets
EU/1/97/049/007-009
Irbesartan Sanofi Winthrop Industrie
Karvea 75 mg film-coated tablets
EU/1/97/049/016-020
Irbesartan Sanofi Winthrop Industrie
Karvea 75 mg tablets
EU/1/97/049/001-003
Irbesartan Sanofi Winthrop Industrie
Karvezide 150 mg/12.5 mg film-coated tablets
EU/1/98/085/011-015
Irbesartan, Hydrochlorothiazide Sanofi Winthrop Industrie
Karvezide 150 mg/12.5 mg tablets
EU/1/98/085/001-003
Irbesartan, Hydrochlorothiazide Sanofi Winthrop Industrie
Karvezide 300 mg/12.5 mg film-coated tablets
EU/1/98/085/016-020
Irbesartan, Hydrochlorothiazide Sanofi Winthrop Industrie
Karvezide 300 mg/12.5 mg tablets.
EU/1/98/085/004-006
Irbesartan, Hydrochlorothiazide Sanofi Winthrop Industrie
Karvezide 300 mg/25 mg film-coated tablets
EU/1/98/085/023-028
Irbesartan, Hydrochlorothiazide Sanofi Winthrop Industrie
Kauliv 20 micrograms/80 microliters solution for injection
EU/1/22/1710/001-002
Teriparatide Strides Pharma (Cyprus) Limited
KAVIGALE 300 mg solution for injection/infusion
EU/1/24/1900/001
Sipavibart AstraZeneca AB
KAYFANDA 1200 microgram hard capsules
EU/1/24/1854/004
Odevixibat Ipsen Pharma
KAYFANDA 200 microgram hard capsules
EU/1/24/1854/001
Odevixibat Ipsen Pharma
KAYFANDA 400 microgram hard capsules
EU/1/24/1854/002
Odevixibat Ipsen Pharma
KAYFANDA 600 microgram hard capsules
EU/1/24/1854/003
Odevixibat Ipsen Pharma
Kefdensis 60 mg solution for injection in pre-filled syringe
EU/1/25/1980/001
Denosumab Stada Arzneimittel AG
Kengrexal 50 mg powder for concentrate for solution for injection/infusion
EU/1/15/994/001
Cangrelor tetrasodium Chiesi Farmaceutici S.p.A.
Kentera
EU/1/03/270/004-005
Oxybutynin hydrochloride Teva B.V.
Kentera 3.9 mg/24 hours transdermal patch
EU/1/03/270/1-2
Oxybutynin Teva B.V.
Keppra 100 mg/ml concentrate for solution for infusion
EU/1/00/146/033
Levetiracetam UCB Pharma S.A.
Keppra 100 mg/ml oral solution
EU/1/00/146/027
Levetiracetam UCB Pharma S.A.
Keppra 1000 mg film-coated tablets
EU/1/00/146/020-026
Levetiracetam UCB Pharma S.A.
Keppra 250 mg film-coated tablets
EU/1/00/146/001-005
Levetiracetam UCB Pharma S.A.
Keppra 500 mg film-coated tablets
EU/1/00/146/006-013
Levetiracetam UCB Pharma S.A.
Keppra 750 mg film-coated tablets
EU/1/00/146/014-019
Levetiracetam UCB Pharma S.A.
Kerendia 10 mg Film-coated tablet
EU/1/21/1616/001-005
Finerenone Bayer AG
Kerendia 20 mg Film-coated tablet
EU/1/21/1616/006-010
Finerenone Bayer AG
Kesimpta 20 mg solution for injection in pre-filled pen
EU/1/21/1532/003-004
Ofatumumab Novartis Europharm Limited
Kesimpta 20 mg solution for injection in pre-filled syringe
EU/1/21/1532/001-002
Ofatumumab Novartis Europharm Limited
Ketoconazole Esteve 200 mg tablets
EU/1/14/965/001
Ketoconazole Esteve Pharmaceuticals S.A.
Kevzara 150 mg solution for injection in pre-filled syringe
EU/1/17/1196/001-002
Sarilumab Sanofi Winthrop Industrie
Kevzara 175 mg/ml solution for injection
EU/1/17/1196/013
Sarilumab Sanofi Winthrop Industrie
Kevzara 200 mg solution for injection in pre-filled syringe
EU/1/17/1196/003-008
Sarilumab Sanofi Winthrop Industrie
KEYTRUDA 25 mg/mL concentrate for solution for infusion
EU/1/15/1024/002
Pembrolizumab Merck Sharp & Dohme BV,
Kigabeq 100 mg Soluble tablet
EU/1/18/1302/001
Vigabatrin Orphelia Pharma SA
Kigabeq 500 mg Soluble tablet
EU/1/18/1302/002
Vigabatrin Orphelia Pharma SA
KIMMTRAK 100 micrograms/0.5 mL concentrate for solution for infusion
EU/1/22/1630/001
Tebentafusp Immunocore Ireland Limited
Kineret 100 mg/0.67 ml solution for injection in pre-filled syringe
EU/1/02/203/005-007
Anakinra Swedish Orphan Biovitrum AB
37 38 39 40 41 42 43
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.